The relation between serotonin levels and insufficient blood pressure decrease during night-time in hypertensive patients

Blood Pressure

Volumn 18, Issue 6, 2009, Pages 367-371

  Topsakal, Ramazan ^a   Kalay, Nihat ^a   Gunturk, Ertugrul Emre ^a   Dogan, Ali ^a   Inanc, Mehmet Tugrul ^a   Kaya, Mehmet Gungor ^a   Ergin, Ali ^a   Yarlioglues, Mikail ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Hypertension; Non dipper; Serotonin

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SEROTONIN; URIC ACID;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CELL LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG TREATMENT FAILURE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NOCTURNAL BLOOD PRESSURE DECREASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE; THROMBOCYTE SEROTONIN LEVEL; TREATMENT DURATION; URIC ACID BLOOD LEVEL;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PLATELETS; BLOOD PRESSURE; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SEROTONIN; SLEEP DISORDERS;

EID: 73649129934     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037050903350788     Document Type: Article

References (16)

1. O'Brien E, Sheridan J, O'Malley K. Dippers and nondippers. Lancet. 1988;2:397-400.
2. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al.. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: The Ohasama Study. J Hypertens. 2002;20:2183-2189.
3. Verdecchia P, Schilacci G, Borgioni C, Ciucci A, Gattobigio R, Guerrieri M, et al.. Altered circadian blood pressure profile and prognosis. Blood Press Monit. 1997;2:347-352.
4. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, et al.. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793-801.
5. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, De Leeuw PW, et al..; Systolic Hypertension in Europe (Syst- Eur) Trial Investigators. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999;282:539-546.
6. Cosigny PM. Endothelin-1 increases arterial sensitivity to 5-hydroxytryptamine. Eur J Pharmacol. 1990;186: 239-245.
7. Villazon M, Padin JF, Tristan H, Enguix MJ, Tristán H, Orallo F, et al.. Functional characterization of serotonin receptors in rat isolated aorta. Biol Pharm Bull. 2002;25: 584-590.
8. Jafri SM, Chandra N, Dhawan S, Soni D, Chandra M, Shanker K. Factors influencing platelet serotonin uptake in essential hypertension. Int J Cardiol. 1992;34:327-333.
9. Guicheney P, Devynck MA, Cloix JF, Pernollet MG, Grichois ML, Meyer P. Platelet 5-HT content and uptake in essential hypertension: role of endogenous digitalis-like factors and plasma cholesterol. J Hypertens. 1988;6: 873-879.
10. Sagnella GA, Jones JC, Shore AC, Markandu ND, MacGregor GA. Evidence for increased levels of a circulating ouabainlike factor in essential hypertension. Hypertension. 1986;8:433-437.
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem. 1972;18: 499-502.
12. Murakami Y, Sano K, Shimado T. Circadian release of serotonin across the coronary bed in patients with endothelial dysfunction. Am J Cardiol. 1997;80:214-216.
13. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, et al.. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle aged men. Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study. Circulation. 1999;99:237-242.
14. Kawamoto R, Tomita H, Oka Y, Kodama A, Ohtsuka N, Kamitani A. Association between uric acid and carotid atherosclerosis in elderly persons. Intern Med. 2005;44: 787-793.
15. Wannamethee SG. Serum uric acid and risk of coronary heart disease. Curr Pharm Des. 2005;11:4125-4132.
16. Pontremoli R, Nicolella C, Viazzi F, Ravera M, Sofia A, Berruti V, et al.. Microalbuminuria is an early marker of target organ damage in essential hypertension. Am J Hypertens. 1998;11:430-438.